22nd week of 2021 patent applcation highlights part 10

Patent application number	Title	Published
22nd week of 2021 patent applcation highlights part 10
20210161964	METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF	2021-06-03
20210161965	KIR3DL1/HLA-B SUBTYPES FOR HEMATOPOIETIC CELL TRANSPLANTATION DONOR SELECTION	2021-06-03
20210161966	METHODS OF TREATING LYSOSOMAL DISORDERS	2021-06-03
20210161967	EXTRACELLULAR VESICLES AND USES THEREOF	2021-06-03
20210161968	USE OF MICRONEEDLE PATCH TO PROMOTE HAIR GROWTH	2021-06-03
20210161969	COMPOSITION COMPRISING EXOSOME AS EFFECTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF ACUTE LIVER FAILURE	2021-06-03
20210161970	METHODS AND USES OF BIOLOGICAL TISSUES FOR VARIOUS STENT AND OTHER MEDICAL APPLICATIONS	2021-06-03
20210161971	ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION	2021-06-03
20210161972	TOPICAL COMPOSITION COMPRISED OF COD LI VER OIL FOR TREATING WOUNDS AND SKIN DISORDERS	2021-06-03
20210161973	AQUEOUS EXTRACT OF GROUND MATERIAL OF PLANARIAN ORGANISMS	2021-06-03
20210161974	MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT	2021-06-03
20210161975	INACTIVATED BACILLUS COAGULANTS AND USES THEREOF FOR REDUCING STRESS	2021-06-03
20210161976	BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER	2021-06-03
20210161977	NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-1 AND USE THEREOF IN INHIBITING STREPTOCOCCUS SUIS BACTERIUM PROLIFERATION	2021-06-03
20210161978	NOVEL STREPTOCOCCUS SUIS BACTERIOPHAGE STR-SUP-3, AND USE THEREOF FOR INHIBITING PROLIFERATION OF STREPTOCOCCUS SUIS STRAINS	2021-06-03
20210161979	CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER	2021-06-03
20210161980	SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT	2021-06-03
20210161981	Methods for Liberating Phosphorus from Organic Matter	2021-06-03
20210161982	PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR ISCHEMIA TREATMENT	2021-06-03
20210161983	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF	2021-06-03
20210161984	Vaporized Medicants and Methods of Use	2021-06-03
20210161986	CAFFEINE COMPOSITIONS AND METHODS OF USE	2021-06-03
20210161987	WATER-IN-OIL NANO-EMULSION OF SAFFRON AND A METHOD OF PREPARING THEREOF	2021-06-03
20210161988	Composition for Treating Diarrhea	2021-06-03
20210161989	APPARATUS AND METHOD FOR PROCESSING ORGANIC BAMBOO LEAF EXTRACT PRODUCTS	2021-06-03
20210161990	STABLE DRY PROBIOTIC COMPOSITIONS FOR SPECIAL DIETARY USES	2021-06-03
20210161991	USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS	2021-06-03
20210161992	PHOSPHORYLCHOLINE CONJUGATES AND USES THEREOF	2021-06-03
20210161993	Method for accelerated healing of burn wounds	2021-06-03
20210161994	IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF	2021-06-03
20210161995	TERLIPRESSIN COMPOSITIONS AND USES THEREOF	2021-06-03
20210161996	Granular Pharmaceutical Composition	2021-06-03
20210161997	TREATING DISEASES VIA TARGETED MODULATION OF GENE SIGNALING NETWORKS	2021-06-03
20210161998	COMPOSITION FOR CELL PROTECTION CONTAINING CYCLO HISTIDINE-PROLINE AS ACTIVE INGREDIENT	2021-06-03
20210161999	COMPOSITIONS AND METHODS RELATED TO OVERCOMING INNATE IMMUNE BARRIERS TO CANCER IMMUNOTHERAPY	2021-06-03
20210162000	PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE	2021-06-03
20210162001	PLANTARICIN NC8 ALPHA BETA MARKEDLY ENHANCES THE EFFECTS OF ANTIBIOTICS	2021-06-03
20210162002	REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF SPINAL CORD INJURY AND ALS	2021-06-03
20210162003	REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF HEMORRHAGIC STROKE	2021-06-03
20210162004	NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER	2021-06-03
20210162005	Fusion Protein Between Short Form Rod-Derived Cone Viability Factor and a Hydrophilic Peptide	2021-06-03
20210162006	Use of CD24 Proteins for Treating Leptin-Deficient Conditions	2021-06-03
20210162007	MODULATING NUCLEAR RECEPTORS AND METHODS OF USING SAME	2021-06-03
20210162008	TISSUE REPAIR	2021-06-03
20210162010	TARGETED HUMAN-INTERFERON FUSION PROTEINS	2021-06-03
20210162011	Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes	2021-06-03
20210162012	COMPOSITIONS OF GLP-1 PEPTIDES AND PREPARATION THEREOF	2021-06-03
20210162013	COMPOSITIONS AND METHODS FOR IMPROVING THE BIOAVAILABILITY OF GLP1 AND ANALOGUES THEREOF	2021-06-03
20210162014	ENCAPSULATION OF ULTRA-STABLE INSULIN ANALOGUES WITH POLYMER MELTS	2021-06-03
20210162015	TOPICAL COMPOSITION FOR IMPROVED HEALING OF OPEN WOUNDS	2021-06-03
20210162016	METHOD OF DELIVERING A SOMATOSTATIN COMPOUND INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE	2021-06-03
20210162017	DIRECTED STEM CELL RECRUITMENT	2021-06-03
20210162018	PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF PRETERM BIRTH	2021-06-03
20210162019	IMMUNODOMINANT PROTEINS AND FRAGMENTS IN MULTIPLE SCLEROSIS	2021-06-03
20210162020	SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM)	2021-06-03
20210162021	MARKER FOR ACID SPHINGOMYELINASE DISORDERS AND USES THEREOF	2021-06-03
20210162022	SEQUENCE SPECIFIC ANTIMICROBIALS	2021-06-03
20210162023	METHODS OF TREATING NEUROFIBROMATOSIS TYPE 1 AND RELATED CONDITIONS WITH ALKALINE PHOSPHATASE	2021-06-03
20210162024	METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS	2021-06-03
20210162025	VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE	2021-06-03
20210162026	TRANSMUCOSAL BOTULINUM TOXIN COMPOSITIONS, KITS, AND METHODS FOR TREATING BLADDER DISORDERS	2021-06-03
20210162027	BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN	2021-06-03
20210162028	Methods for Inducing Intermittent Fasting and Modulating Autophagy	2021-06-03
20210162029	COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF SKIN DISEASES AND DISORDERS WITH LEKTI	2021-06-03
20210162030	COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER WITH LEKTI	2021-06-03
20210162031	METHODS AND COMPOSITIONS FOR TREATING CANCERS	2021-06-03
20210162032	CANCER VACCINES FOR BREAST CANCER	2021-06-03
20210162033	BURKHOLDERIA PSEUDOMALLEI COMPLEX OUTER MEMBRANE VESICLES AS ADJUVANTS	2021-06-03
20210162034	MDR E. COLI SPECIFIC ANTIBODY	2021-06-03
20210162035	Zika Vaccines and Methods of Use	2021-06-03
20210162036	IMPROVED DILUENT FOR CELL-ASSOCIATED ALPHAHERPESVIRUS VACCINE	2021-06-03
20210162037	INFLUENZA MRNA VACCINES	2021-06-03
20210162038	PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS	2021-06-03
20210162039	MULTIEPITOPE FUSION ANTIGENS FOR VACCINATION AND METHODS OF MAKING AND USING SUCH ANTIGENS	2021-06-03
20210162040	TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUS	2021-06-03
20210162041	HELPER EPITOPE PEPTIDE AND APPLICATION THEREOF	2021-06-03
20210162042	NOVEL METHODS FOR MANUFACTURING AN ADJUVANT	2021-06-03
20210162043	TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA	2021-06-03
20210162044	METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS	2021-06-03
20210162045	HUMAN ENDOTHELIN RECEPTOR ANTIBODY AND USE THEREOF	2021-06-03
20210162046	EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS	2021-06-03
20210162047	A Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It.	2021-06-03
20210162048	Photoswitchable HDAC Inhibitors	2021-06-03
20210162049	RETINOID TOPICAL COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS	2021-06-03
20210162050	TOPICAL FORMULATIONS BASED ON IONIC SPECIES FOR SKIN TREATMENT	2021-06-03
20210162051	AQUEOUS-BASED COMPOSITIONS	2021-06-03
20210162052	Compositions for Transfecting Resistant Cell Types	2021-06-03
20210162053	NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS	2021-06-03
20210162054	HYDRAZINYL-INDOLE COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE	2021-06-03
20210162055	MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES	2021-06-03
20210162056	TARGETING MACULA DENSA CELLS AS A NEW THERAPEUTIC APPROACH FOR KIDNEY DISEASE	2021-06-03
20210162057	CONJUGATES AND METHODS OF USING THE SAME	2021-06-03
20210162058	ENGINEERED POLYPEPTIDE CONJUGATES USING TRANSGLUTAMINASE	2021-06-03
20210162059	Human Antibodies to S. Aureus Hemolysin A Toxin	2021-06-03
20210162060	BIO-ORTHOGONAL DRUG ACTIVATION	2021-06-03
20210162061	IMMUNOCONJUGATES COMPRISING SIGNAL REGULATORY PROTEIN ALPHA	2021-06-03
20210162062	ANTIBODY-DRUG CONJUGATES TARGETING uPARAP	2021-06-03
20210162063	COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS	2021-06-03
20210162064	Nucleic Acid Carriers And Therapeutic Methods Of Use	2021-06-03
20210162065	MULTI-FUNCTIONAL CANCER DRUG DELIVERY NANODEVICE FOR PRECISION MEDICINE	2021-06-03

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees